Regeneron Pharmaceuticals (REGN) Change in Cash (2009 - 2026)
Regeneron Pharmaceuticals (REGN) posted quarterly Change in Cash of -$504.6 million for Q2 2026, up 53.17% year-over-year from -$329.4 million in Q2 2025, and down 229.59% quarter-over-quarter from -$153.1 million in Q1 2026.
Regeneron Pharmaceuticals (REGN) Change in Cash (2009 - 2026) Analysis & Trends
Regeneron Pharmaceuticals' Change in Cash history runs 18 years deep, the most recent figure standing at -$504.6 million for Q2 2026.
- In Q2 2026, Change in Cash rose 53.17% year-over-year to -$504.6 million; the TTM figure through Jun 2026 stood at $450.4 million (up 415.33% YoY), while the FY2025 annual figure was $634.7 million, up 355.1% from the prior year.
- Change in Cash for Q2 2026 stood at -$504.6 million, down from -$153.1 million in the prior quarter.
- The five-year high for Change in Cash was $809.4 million in Q1 2023, with the low at -$2.0 billion in Q2 2023.
- The 5-year median for Change in Cash is $89.9 million (2022), against an average of -$24.0 million.
- The sharpest annual moves came in 2023 and 2025: Change in Cash plunged 4106.28% in 2023, then jumped 571.88% in 2025.
- Regeneron Pharmaceuticals' Change in Cash stood at -$385.4 million in 2022, then soared by 249.87% to $577.6 million in 2023, then dropped by 17.38% to $477.2 million in 2024, then rose by 27.95% to $610.6 million in 2025, then tumbled by 182.64% to -$504.6 million in 2026.
- Business Quant data shows REGN's Change in Cash at -$504.6 million in Q2 2026, -$153.1 million in Q1 2026, and $610.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -170.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -504.60 Mn |
| Mar 31, 2026 | -153.10 Mn |
| Dec 31, 2025 | 610.60 Mn |
| Sep 30, 2025 | 497.50 Mn |
| Jun 30, 2025 | -1.08 Bn |
| Mar 31, 2025 | 604.00 Mn |
| Dec 31, 2024 | 477.20 Mn |
| Sep 30, 2024 | 83.60 Mn |
| Jun 30, 2024 | -681.60 Mn |
| Mar 31, 2024 | -128.00 Mn |
| Dec 31, 2023 | 577.60 Mn |
| Sep 30, 2023 | 210.50 Mn |
| Jun 30, 2023 | -1.98 Bn |
| Mar 31, 2023 | 809.40 Mn |
| Dec 31, 2022 | -385.40 Mn |
| Sep 30, 2022 | 96.20 Mn |
| Jun 30, 2022 | 49.40 Mn |
| Mar 31, 2022 | 461.10 Mn |
| Dec 31, 2021 | -546.80 Mn |
| Sep 30, 2021 | 1.36 Bn |